NASUS PHARMA LTD NSRX
$3.50
-0.4% 52w: $2.01 – $9.15
Latest 13F among current holders filed 1 month ago (May 15, 2026)
Price — last 12 months
research preview data2.015.589.15
Aug 13, 2025 Jul 2, 2026
Institutional holders
9
+7 QoQ
13F value
$4.8M
+22081.8% QoQ
Smart-money holders
3
signal tier ≥ 2
New smart buyers
3
Q1 2026
Institutional value by quarter
Number of holders
Who owns NSRX?
Q1 2026 filings| Fund | Type | Shares | Value | % of fund | Change |
|---|---|---|---|---|---|
| Balyasny Asset Management L.P. | Multistrat pod | 898.5K | $2.0M | 0.0% | New |
| Cable Car Capital, LP ★2 | Fundamental diversified | 602.0K | $1.3M | 0.6% | New |
| Velan Capital Investment Management LP ★2 | Fundamental concentrated | 359.4K | $798K | 0.5% | New |
| Hudson Bay Capital Management LP | Multistrat pod | 134.8K | $299K | 0.0% | New |
| Bleichroeder LP | Other | 89.8K | $199K | 0.0% | New |
| Empery Asset Management, LP ★2 | Fundamental concentrated | 45.8K | $102K | 0.1% | New |
| HRT FINANCIAL LP | Diversified mechanical | 38.9K | $86K | 0.0% | New |
| UBS Group AG | Bank broker | 3.1K | $7K | 0.0% | +718.5% |
| MORGAN STANLEY | Bank broker | 2.0K | $4K | 0.0% | Held |
Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.
Explore related
Top funds holding NSRX
More healthcare stocks held by institutions